Use of PET-CT for the assessment of treatment results in patients with sarcoidosis

YAKAR A., YAKAR F., SEZER M., Bayram M., Erdogan E. B., Ozkan D., ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.127, pp.274-282, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 127
  • Publication Date: 2015
  • Doi Number: 10.1007/s00508-014-0647-9
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.274-282
  • Keywords: PET-CT, Sarcoidosis, Methylprednisolone, Indomethacine, Spirometry, POSITRON-EMISSION-TOMOGRAPHY, CONVERTING-ENZYME, GA-67, SCANS, THERAPY
  • Bezmialem Vakıf University Affiliated: Yes


Background and aim Sarcoidosis is a multisystem disease of unknown origin. Determining the involvement and the response to the treatment is important. The aim of this study was to identify the effects of methylprednisolone and indomethacine on metabolic activity and pulmonary function test parameters in patients with sarcoidosis.